BibTex format
@article{Zamorano:2016:10.1002/ejhf.654,
author = {Zamorano, JL and Lancellotti, P and Rodriguez, Muñoz D and Aboyans, V and Asteggiano, R and Galderisi, M and Habib, G and Lenihan, DJ and Lip, GY and Lyon, AR and Lopez, Fernandez T and Mohty, D and Piepoli, MF and Tamargo, J and Torbicki, A and Suter, TM and Zamorano, JL and Aboyans, V and Achenbach, S and Agewall, S and Badimon, L and Barón-Esquivias, G and Baumgartner, H and Bax, JJ and Bueno, H and Carerj, S and Dean, V and Erol, Ç and Fitzsimons, D and Gaemperli, O and Kirchhof, P and Kolh, P and Lancellotti, P and Lip, GY and Nihoyannopoulos, P and Piepoli, MF and Ponikowski, P and Roffi, M and Torbicki, A and Vaz, Carneiro A and Windecker, S and AuthorsTask, Force Members and ESC, Committee for Practice Guidelines CPG},
doi = {10.1002/ejhf.654},
journal = {European Journal of Heart Failure},
pages = {9--42},
title = {2016 ESC Position Paper on cancer treatments and cardiovascular toxicity developed under the auspices of the ESC Committee for Practice Guidelines: The Task Force for cancer treatments and cardiovascular toxicity of the European Society of Cardiology (ESC)},
url = {http://dx.doi.org/10.1002/ejhf.654},
volume = {19},
year = {2016}
}